Strata Critical Medical (SRTA) Receivables (2020 - 2026)

Strata Critical Medical (SRTA) has reported Receivables for 7 consecutive years, with $39.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables rose 78.97% year-over-year to $39.6 million; the TTM figure through Mar 2026 stood at $39.6 million (up 78.97% YoY), while the FY2025 annual figure was $40.0 million, up 101.58% from the prior year.
• Receivables retreated to $39.6 million in Q1 2026 per SRTA's latest filing, from $40.0 million in the prior quarter.
• Across five years, Receivables topped out at $40.0 million in Q4 2025 and bottomed at $6.0 million in Q1 2022.
• Historically, Receivables has averaged $22.5 million across 5 years, with a median of $22.1 million in 2025.
• Annual changes were most pronounced in 2022 — Receivables soared 464.95% — and 2025, when it retreated 6.04%.
• Strata Critical Medical's Receivables stood at $10.9 million in 2022, then soared by 93.11% to $21.0 million in 2023, then declined by 5.63% to $19.8 million in 2024, then surged by 101.58% to $40.0 million in 2025, then dropped by 0.89% to $39.6 million in 2026.
• Business Quant data shows SRTA's Receivables at $39.6 million in Q1 2026, $40.0 million in Q4 2025, and $37.5 million in Q3 2025.